Novation Inks Supply Deal for Bayer Molecular Diagnostics Products | GenomeWeb

NEW YORK, July 15 (GenomeWeb News) - Novation, the supply company for VHA and University HealthSystem Consortium, has signed a three-year agreement to make Bayer Diagnostics' molecular diagnostics products available to the 2,300 hospitals served by the two healthcare alliances.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.